Impairment in the number and function of CD34+/KDR+ circulating cells in diabetes and obesity with functional improvement after thymosin β4 treatment
Conclusion: A significant impairment in the number and function of CD34+/KDR+ circulating cells in ZDF rats was observed. The use of Tβ4 as a potential novel therapeutic target in improving migratory and angiogenic activities may prove to be important in diabetes and obesity.
Source: Cardiovascular Endocrinology - Category: Cardiology Tags: Original articles Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Eating Disorders & Weight Management | Endocrinology | Gastroschisis Repair | Heart | Obesity